Facility

Baxter (NYSE:BAX) is planning on spending $50 million to expand a sterile fill/finish manufacturing facility in Bloomington, Ind.  Baxter’s BioPharma Solutions business will manage the site, including a new 25,000-ft2 warehouse, a new filling line for flexible plastic containers and a high-speed automated syringe fill line.  Baxter hopes to wrap up manufacturing at the site in…

Transitioning from traditional batch to continuous manufacturing provides greater throughput, but it requires near real-time data analysis to proactively address potential problems. Continuous manufacturing (CM) is gaining popularity in the pharmaceutical industry because it represents an improved approach for small molecule drug product development compared to traditional batch manufacturing methods. CM allows for the production…

Grifols (MCE:GRF and NSDQ:GRFS) posted third-quarter earnings yesterday that came in ahead of analysts’ projections, but its revenue fell short of the consensus forecast. The Barcelona-based manufacturer of blood-plasma products reported a net profit of €485.7 million on revenue of €4.0 billion for the quarter ended Sept. 30, 2020. Growth in constant currency was 7.6% compared with…

Thermo Fisher Scientific Inc. (NYSE:TMO) and Innoforce have agreed to set up a new pharma services facility in Hangzhou, China for biologics and drug development and manufacturing.  Innoforce is a Hangzhou, China-based contract development and manufacturing company. The two companies expect to complete the facility in 2022.   The site will become part of Thermo Fisher’s…

Among the numerous logistical challenges to providing COVID-19 vaccines around the globe, temperature is receiving little attention. Relatively few logistics or healthcare organizations have freezers capable of cooling down to –80° C (–112° F). But vaccines using gene-based technology known as messenger RNA (mRNA) require such ultralow temperatures. Against that backdrop, Stirling Ultracold has announced…

Thermo Fisher Scientific (NYSE:TMO), the maker of scientific instruments, reagents and consumables, is having a banner year. The Waltham, Mass.-based company’s stock has hit an all-time high of $481.99. That amounts to a 48% increase since the beginning of the year. Thermo Fisher raked in $2 billion in COVID-19 revenue from July to September, driving a…

Aphena Pharma Solutions recently announced that it is spending $21 million to expand its Solid Dose Division in Cookeville, Tenn Aphena Pharma has purchased a 500,000 ft2 property, purpose-built for FDA manufacturing and packaging operations. Renovations have already started to turn the site into a state-of-the-art pharmaceutical packaging and distribution facility that will also serve…

Hologic (NSDQ:HOLX) is spending $50 million — including $14 million during its most recent quarter — to boost its production of COVID-19 tests. The U.S. government is providing $7.6 million to support the effort. Hologic’s business partner Stratec is also doubling the production of the Panther instruments that run Hologic assays. Get the full story on our sister site…

Moderna (NSDQ:MRNA) and Catalent (NYSE:CTLT) today announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine candidate (mRNA-1273) at Catalent’s biologics facility in Bloomington, Ind. Catalent will provide vial filling and packaging capacity, as well as additional staffing required for 24×7 manufacturing operations at the site to support production of an initial 100 million…

Legacy Pharmaceutical Packaging recently announced that it has bought a 215,000-square-foot open-space facility near its St. Louis area headquarters to support widescale third-party logistics and distribution services. The new facility, announced last week, nearly doubles Legacy’s total footprint to more than 500,000 square feet. The new space allows Legacy Pharmaceutical Packaging to significantly grow its…